BetterScholar BetterScholar

Alan Barge

Blood
7
Role
Title
Level Year L/R
🐢 A Randomized, Double-Blind, Placebo-Controlled, Phase III Study of Filgrastim in Remission Induction and Consolidation Therapy for Adults With De Novo Acute Myeloid Leukemia
12 auth. G. Heil, D. Hoelzer, Miguel A Sanz, K. Lechner, J. L. Liu Yin, Giuseppe Papa, ... Luc Noens, J. Szer, A. Ganser, C. O'brien, James Matcham, Alan Barge 		7 1997
7
🐢
🐜 A randomized, double-blind, placebo-controlled study with pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) as an adjunct to chemotherapy for adults with de novo acute myeloid leukemia.
13 auth. Eric Archimbaud, O. Ottmann, J. A. L. Yin, Klaus Lechner, Hervé Dombret, M. Sanz, Gerhard Heil, P. Fenaux, Wolfram Brugger, Alan Barge, ... Caroline O’Brien-Ewen, James Matcham, Dieter Hoelzer 		4 1999
4
🐜